SI080011: Hydrochlorothiazide-13C d2 Pack Size:25 mg 1-[N-[2-[4-[[2-(2-Amino-4-thiazolyl)acetyl]amino]phenyl]ethyl]-N-[(2R)-2-hydroxy-2-phenylethyl]carbamate]- β-D-Glucopyranuronic Acid

1-[N-[2-[4-[[2-(2-Amino-4-thiazolyl)acetyl]amino]phenyl]ethyl]-N-[(2R)-2-hydroxy-2-phenylethyl]carbamate]- β-D-Glucopyranuronic Acid

3)Sialyl TF Antigen (Fmoc-Threonine

3)LacNAc-β-Butyl-Carboxylic Acid / Galα(1

with relevance to immune targeting and pathogen-recognition research

/ MUC1(126-149)-STn(131

SI080011: Hydrochlorothiazide-13C d2 Pack Size:25 mg 1-[N-[2-[4-[[2-(2-Amino-4-thiazolyl)acetyl]amino]phenyl]ethyl]-N-[(2R)-2-hydroxy-2-phenylethyl]carbamate]- β-D-Glucopyranuronic AcidC613CH6D2ClN15N2O4S2 300. 74 Hypertension, Congestive Heart Failure, Kidney Stone Hydrochlorothiazide 13C d2 6 Chloro 3,4 dihydro 2H 1,2,4 benzothiadiazine 13C d2 sulfonamide 1,1 Dioxide; Apo hydro 13C,15N2 d2; Aquazide h 13C 15N2 d2; Dichlotride 13C 15N2 d2; Diurizid 13C 15N2 d2; Oretic 13C 15N2 d2; HCTZ 13C 15N2 d2; HZT 13C 15N2 d2